Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Cognition and Behavior

The Dorsal Raphe Regulates the Duration of Attack through the Medial Orbitofrontal Cortex and Medial Amygdala

Jacob Nordman and Zheng Li
eNeuro 14 October 2020, 7 (5) ENEURO.0331-20.2020; https://doi.org/10.1523/ENEURO.0331-20.2020
Jacob Nordman
1Section on Synapse Development Plasticity, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892
2National Institute of General Medical Sciences, National Institutes of Health, Bethesda, MD 20892
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jacob Nordman
Zheng Li
1Section on Synapse Development Plasticity, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zheng Li
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    CaMKIIα+ neurons of the DR are activated by attack. A–F, Mice (10 weeks of age) were examined for aggression using the RI assay. Mice were perfused 60 min after the assay for immunostaining. A, Representative images of brain sections stained for c-Fos and CaMKIIα in the DR from resident or control animals 1 h after the RI test. B, Representative high-magnification images of CaMKIIα+ cells in the DR that were positive for c-Fos. C, D, Percentage of c-Fos+ cells that colocalize with CaMKIIα+ and DAPI+ cells in resident and control mice for A. E, F, Quantification of CaMKIIα+ (E) and DAPI+ (F) cells in the DR in resident and control mice. G, Representative images of brain sections stained for CaMKIIα and TpH2 throughout the DR (bregma −4.34 to −4.84 mm). High-magnification image of the DR is taken from a brain slice at bregma position −4.84, as this is where the majority of TpH2+ cells can be found. H, Quantification of total number of CaMKIIα+ and TpH2+ cells in the DR. Asterisks indicate statistical significance of CaMKIIα (green) or TpH2 (red) from merged set at the specified coordinate. One slice was quantified per area per animal. Animal number is indicated in parentheses. I, Percentage of DAPI+ cells in the DR that co-label for CaMKIIα and TpH2. Asterisks indicate statistical significance of CaMKIIα (green) or TpH2 (red) from merged set at the specified coordinate. Only cells within the DR were counted. Scale bars: 200 μm (A, G) and 25 μm (B). Data are presented as mean ± SEM; *p < 0.05, **p < 0.01. Statistics can be found in Table 2.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Inhibition of CaMKIIα+ DR neurons shortens attack. A, Representative high-magnification and low-magnification images of ChR2-mCherry and ArchT-EYFP expression in the DR three weeks after viral injection. B, Representative images of brain sections stained for c-Fos in the DR of mice injected with ChR2-EYFP or GFP and photostimulated with 473 nm light (pulsed at 10 Hz for 10 s). C, D, Percentage of YFP+ or GFP+ cells that colocalize with c-Fos (C) and quantification of total DAPI+ cells (D) in the DR after photostimulation for B. Only cells within the DR were counted. E, F, Representative images of brain sections expressing ChR2 (E) or ArchT (F) under the CaMKIIα promoter co-stained for TpH2 in the DR. G, Quantification of ChR2 or ArchT (opsin) expressing cells that were stained positive for TpH2. Only cells within the DR were counted. One slice was quantified per area per animal. Animal number is indicated in parentheses. H, L, P, Schematic drawing of viral injection (AAV expressing ChR2 and ArchT or GFP control virus), placement of optic fiber, and stimulation procedure. Opsin expressing mice in H–K and opsin stimulated mice in L-S were injected with ChR2 virus and ArchT virus. The same mice were stimulated with 473 or 561 nm light on separate days. I, Raster plots of attack events during each interaction episode (rows in the raster plot, defined as the period from 20 s before to 20 s after the onset of a spontaneous attack) for each mouse. All attack events during the testing period are shown. J, % of episodes (rows) in which mice attacked at each time point in I; red and dark lines indicate the mean, pink and gray areas indicate SEM. K, Quantification of average attack time per mouse during the 10 s after the onset of a spontaneous attack, as represented in the boxed area in J. M, Raster plots of trials (rows) of mice photostimulated with 473 nm light at the DR when the mouse was not attacking. All trials are aligned to the onset of light. N, % of trials in which mice attacked at each time point in M; red and dark lines indicate the mean, pink and gray areas indicate SEM. O, Quantification of attack time per mouse before and during light stimulation for M. Q, Raster plots of trials (rows) of mice photostimulated with 561 nm light at the DR during an attack. All trials are aligned to onset of light. R, % of trials in which mice attacked at each time point in Q; red and dark lines indicate the mean, pink and gray areas indicate SEM. S, Quantification of attack time per mouse before and during light stimulation for Q. Scale bars: 200 μm (low-magnification image; top; A, E, F); 50 μm (high-magnification image; bottom; A, E, F); 10 μm (B). Data are presented as mean ± SEM; ***p < 0.001. Statistics can be found in Table 2.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    DR neurons project to and activate the MeOC. A–E, Schematic drawing of ChR2-EYFP viral injection and representative images of ChR2 expression in DR neurons (B) and DR projections at the MeOC (C–E) three weeks later. F–K, c-Fos labeling of mice photostimulated at the DR-MeOC. L, M, Quantification of total number of cells (L) and percentage (M) of c-Fos+ cells in the MeOC for D–K. Only cells within the MeOC were counted. One slice was quantified per area per animal. Animal number is indicated in parentheses. Scale bars: 200 μm (A, B; low-magnification images in C, D) and 50 μm (high-magnification images in C, D). Data are presented as mean ± SEM; **p < 0.01, ***p < 0.001. Statistics can be found in Table 2.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    DR neurons project to and activate the MeA. A–E, Schematic drawing of ChR2-EYPF injections into the DR and representative images of ChR2 expression in DR neurons (B) and axons at the MeA (C–E) three weeks later. F–K, c-Fos labeling of mice photostimulated at the DR-MeA. L–U, Quantification of total number of cells (L–M) and percentage (Q–U) of c-Fos+ cells in the MeA (MeAa, anterior MeA; MeApd, posteriordorsal MeA; MeApv, posteriorventral MeA) for D–K. Only cells within the MeA were counted. One slice was quantified per area per animal. Animal number is indicated in bars of bar graphs. Scale bars: 200 μm (A); 200 μm (low-magnification images of B–D, low-magnification images of F–K); 50 μm (high-magnification images of F–K). Data are presented as mean ± SEM; *p < 0.05, **p < 0.01. Statistics can be found in Table 2.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Inhibition of CaMKIIα+ DR input to the MeOC shortens attack. A, E, I, Schematic drawing of viral injection (AAV expressing ChR2 and ArchT or GFP control virus), placement of optic fiber, and stimulation procedure. Opsin expressing mice in A–D and opsin stimulated mice in E–L were injected with ChR2 virus and ArchT virus. The same mice were stimulated with 473 or 561 nm light on separate days. B, Raster plots of attack events during each interaction episode (rows in the raster plot, defined as the period from 20 s before to 20 s after the onset of a spontaneous attack) for each mouse. All attack events during the testing period are shown. C, % of episodes (rows) in which mice attacked at each time point in B; red and dark lines indicate the mean, pink and gray areas indicate SEM. D, Quantification of average attack time per mouse during the 10 s after the onset of a spontaneous attack, as represented in the boxed area in C. F, Raster plots of trials (rows) of mice photostimulated with 473 nm light at the DR-MeOC when the mouse was not attacking. G, % of trials in which mice attacked at each time point in F; red and dark lines indicate the mean, pink and gray areas indicate SEM. H, Quantification of attack time per mouse before and during light stimulation for F. J, Raster plots of trials (rows) of mice photostimulated with 561 nm light at the DR-MeOC during an attack. K, % of trials in which mice attacked at each time point in J; red and dark lines indicate the mean, pink and gray areas indicate SEM. L, Quantification of attack time per mouse before and during light stimulation for J. Data are presented as mean ± SEM; **p < 0.01. Statistics can be found in Table 2.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Effects on attack of CaMKIIα+ DR input to the MeA. A, E, I, Schematic drawing of viral injection (AAV expressing ChR2 and ArchT or GFP control virus), placement of optic fiber, and stimulation procedure. Opsin expressing mice in A–D and opsin stimulated mice in E–L were injected with ChR2 virus and ArchT virus. The same mice were stimulated with 473 or 561 nm light on separate days. B, Raster plots of attack events during each interaction episode (rows in the raster plot, defined as the period from 20 s before to 20 s after the onset of a spontaneous attack) for each mouse. All attack events during the testing period are shown. C, % of episodes (rows) in which mice attacked at each time point in B; red and dark lines indicate the mean, pink and gray areas indicate SEM. D, Quantification of average attack time per mouse for the 10 s after the onset of a spontaneous attack, as represented in the boxed area in C. F, Raster plots of trials (rows) of mice photostimulated with 473 nm light at the DR-MeA when the mouse was not attacking. G, % of trials in which mice attacked at each time point in F; red and dark lines indicate the mean, pink and gray areas indicate SEM. H, Quantification of attack time per mouse before and during light stimulation for F. J, Raster plots of trials (rows) of mice photostimulated with 561 nm light at the DR-MeA during an attack. K, % of trials in which mice attacked at each time point in J; red and dark lines indicate the mean, pink and gray areas indicate SEM. L, Quantification of attack time per mouse before and during light stimulation for J. Data are presented as mean ± SEM. Statistics can be found in Table 2.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    Activation of the DR-MeOC prolongs attack and activation of the DR-MeA shortens attack. Mice were injected with ChR2 virus or GFP virus into the DR and optical fibers were placed into the MeOC (A, E) or the MeA (I, M). RI tests were performed eight weeks later. Separate groups of mice were used for A–H and I–P. B, Raster plots of attack events during each interaction episode (rows in the raster plot, defined as the period from 20 s before to 20 s after the onset of a spontaneous attack) for each mouse. All attack events during the testing period are shown. C, % of episodes (rows) in which mice attacked at each time point in B; red and dark lines indicate the mean, pink and gray areas indicate SEM. D, Quantification of average attack time per mouse for the 10 s after the onset of a spontaneous attack, as represented in the boxed area in C. F, Raster plots of trials (rows) of mice photostimulated with 473 nm light at the DR-MeOC during an attack. G, % of trials in which mice attacked at each time point in F; red and dark lines indicate the mean, pink and gray areas indicate SEM. H, Quantification of attack time per mouse before and during light stimulation for F. J, Raster plots of attack events during each interaction episode (rows in the raster plot, defined as the period from 20 s before to 20 s after the onset of a spontaneous attack) for each mouse. All attack events during the testing period are shown. K, % of episodes (rows) in which mice attacked at each time point in J; red and dark lines indicate the mean, pink and gray areas indicate SEM. L, Quantification of average attack time per mouse for the 10 s after the onset of a spontaneous attack, as represented in the boxed area in J. N, Raster plots of trials (rows) of mice photostimulated with 473 nm light at the DR-MeA during an attack. O, % of trials in which mice attacked at each time point in N; red and dark lines indicate the mean, pink and gray areas indicate SEM. P, Quantification of attack time per mouse before and during light stimulation for N. Data are presented as mean ± SEM; ***p < 0.001. Statistics can be found in Table 2.

Tables

  • Figures
    • View popup
    Table 1.

    Key resources table

    Resource typeSpecific reagent or resourceSource or referenceIdentifiersDilution or concentration
    Organism/strainC57BL/6JCharles RiverStrain code: 556 
    AntibodyCaMKIIa (Cba-2) mouse monoclonal antibodyAbcamCatalog #1373001:250 dilution
    Antibodyc-Fos rabbit polyclonal antibodyAbcamCatalog #ab1902891:2000 dilution
    AntibodyGFP polyclonal antibodyMBLCatalog #5981:1000 dilution
    AntibodyAnti-TpH2 antibodyAbcamCatalog #ab1845051:500 dilution
    AntibodyAlexa Fluor 488 goat anti-mouse IgGThermoFisherCatalog #A-106801:200 dilution
    AntibodyAlexa Fluor 555 goat anti-mouse IgGThermoFisherCatalog #A-214221:200 dilution
    AntibodyAlexa Fluor 488 goat anti-rabbit IgGThermoFisherCatalog #A-110341:200 dilution
    AntibodyAlexa Fluor 555 goat anti-rabbit IgGThermoFisherCatalog #A-214281:200 dilution
    Bacterial or viral strainAAV2/9.CaMKIIa (1.3 kb). hChR2 (E123A)-mCherry.WPRE. hGHAddgeneCatalog #35505-AAV9≥1 × 10¹³ vg/ml, 500 nl injected
    Bacterial or viral strainAAV2/9.CaMKIIa (1.3 kb). hChR2 (E123A)-eYFP.WPRE. hGHAddgeneCatalog #35506-AAV9≥1 × 10¹³ vg/ml, 500 nl injected
    Bacterial or viral strainAAV2/9.CaMKIIa (1.3 kb).ArchT 3.0-eYFP.WPRE. hGHAddgeneCatalog #99039-AAV9≥1 × 10¹³ vg/ml, 500 nl injected
    Bacterial or viral strainpRRlsin.eGFPIn house  
    Commercial assay or kitMetabondParkellCatalog #S380 
    Commercial assay or kitDental cementDuraLayCatalog #602-7395 
    Commercial assay or kitVectashield HardSet Antifade Mounting Medium with DAPIVector LaboratoriesCatalog #H-1500 
    Software; algorithmSigmaPlotIBM https://www.ibm.com  
    • View popup
    Table 2

    Statistical table

    DataMethodFactornT, U, or F statp valuePost hoc correction
    Fig. 1C Mann–WhitneyResident vs control6, 7U = 20.008
    Fig. 1D Mann–WhitneyResident vs control6, 7U = 50.027
    Fig. 1E Student’s t testResident vs control6, 7T(11) = 0.1640.872
    Fig. 1F Student’s t testResident vs control6, 7T(11) = 0.0620.952
    Fig. 1H One-way ANOVA# of cells at bregma −4.845, 5F(2,14) = 13.339<0.001Tukey’s
    One-way ANOVA# of cells at bregma −4.605, 5F(2,14) = 6.3570.013Tukey’s
    One-way ANOVA# of cells at bregma −4.345, 5F(2,14) = 168.490<0.001Tukey’s
    Fig. 1I One-way ANOVA% of DAPI at bregma −4.845, 5F(2,14) = 13.859<0.001Tukey’s
    One-way ANOVA% of cells at bregma −4.605, 5F(2,14) = 4.4930.035Tukey’s
    One-way ANOVA% of cells at bregma −4.345, 5F(2,14) = 20.455<0.001Tukey’s
    Fig. 2C Mann–WhitneyChR2 vs GFP6, 6U = 00.005
    Fig. 2D Student’s t testChR2 vs GFP6, 6T(10) = 0.2030.843
    Fig. 2G One-way ANOVATpH2 vs ChR25, 5F(2,17) = 13.714<0.001Tukey’s
    One-way ANOVATpH2 vs ArchT5, 5F(2,17) = 20.868<0.001Tukey’s
    Fig. 2K Student’s t testOpsin vs GFP5, 4T(7) = 0.7930.454
    Fig. 2O Student’s t testBefore light onset (10 s)5, 4T(7) = −0.6070.563
    Student’s t testDuring light (10 s)5, 4T(7) = 0.8820.407
    Fig. 2S Student’s t testBefore light onset (10 s)5, 3T(6) = 0.1360.896
    Student’s t testDuring light (10 s)5, 3T(6) = −10.784<0.001
    Fig. 3L Student’s t testChR2 vs GFP at bregma 2.686, 6T(10) = 0.3250.752
    Student’s t testChR2 vs GFP at bregma 2.686, 6T(10) = 0.8900.346
    Student’s t testChR2 vs GFP at bregma 2.346, 6T(10) = 0.3960.701
    Fig. 3M Student’s t testChR2 vs GFP at bregma 2.346, 6T(10) = 8.033<0.001
    Student’s t testChR2 vs GFP at bregma 2.106, 6T(10) = 3.8500.003
    Student’s t testChR2 vs GFP at bregma 2.106, 6T(10) = 7.965<0.001
    Fig. 4L Student’s t testChR2 vs GFP6, 6T(10) = 0.4740.646
    Fig. 4M Student’s t testChR2 vs GFP6, 6T(10) = 0.5580.589
    Fig. 4N Student’s t testChR2 vs GFP6, 6T(10) = 0.2580.801
    Fig. 4O Student’s t testChR2 vs GFP6, 6T(10) = 1.1000.297
    Fig. 4P Student’s t testChR2 vs GFP6, 6T(10) = 1.2030.257
    Fig. 4Q Student’s t testChR2 vs GFP6, 6T(10) = 4.693<0.001
    Fig. 4R Student’s t testChR2 vs GFP6, 6T(10) = 2.7450.021
    Fig. 4S Student’s t testChR2 vs GFP6, 6T(10) = 3.1040.011
    Fig. 4T Student’s t testChR2 vs GFP6, 6T(10) = 1.5970.141
    Fig. 4U Student’s t testChR2 vs GFP6, 6T(10) = 2.5250.030
    Fig. 5D Student’s t testOpsin vs GFP4, 3T(5) = 1.1010.321
    Fig. 5H Student’s t testBefore light onset (10 s)4, 3T(5) = 0.8450.437
    Mann–WhitneyDuring light (10 s)4, 3U = 280.952
    Fig. 5L Student’s t testBefore light onset (10 s)4, 3T(5) = 0.6320.555
    Student’s t testDuring light (10 s)4, 3T(5) = −6.606<0.001
    Fig. 6D Student’s t testOpsin vs GFP5, 4T(7) = 0.1370.895
    Fig. 6H Student’s t testBefore light onset (10 s)4, 3T(5) = 0.8450.437
    Mann–WhitneyDuring light (10 s)4, 3T(5) = 01.000
    Fig. 6L Student’s t testBefore light onset (10 s)6, 4T(8) = −1.2170.278
    Student’s t testDuring light (10 s)6, 4T(8) = 0.7430.491
    Fig. 7D Student’s t testOpsin vs GFP4, 3T(5) = 1.1300.310
    Fig. 7H Student’s t testBefore light onset (10 s)4, 3T(5) = 1.4250.214
    Student’s t testDuring light (10 s)4, 3T(5) = 8.871<0.001
    Fig. 7L Student’s t testOpsin vs GFP6, 4T(8) = 1.0100.342
    Fig. 7P Student’s t testBefore light onset (10 s)6, 4T(8) = 0.2290.826
    Student’s t testDuring light (10 s)6, 4T(8) = −12.538<0.001
Back to top

In this issue

eneuro: 7 (5)
eNeuro
Vol. 7, Issue 5
September/October 2020
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Dorsal Raphe Regulates the Duration of Attack through the Medial Orbitofrontal Cortex and Medial Amygdala
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
The Dorsal Raphe Regulates the Duration of Attack through the Medial Orbitofrontal Cortex and Medial Amygdala
Jacob Nordman, Zheng Li
eNeuro 14 October 2020, 7 (5) ENEURO.0331-20.2020; DOI: 10.1523/ENEURO.0331-20.2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
The Dorsal Raphe Regulates the Duration of Attack through the Medial Orbitofrontal Cortex and Medial Amygdala
Jacob Nordman, Zheng Li
eNeuro 14 October 2020, 7 (5) ENEURO.0331-20.2020; DOI: 10.1523/ENEURO.0331-20.2020
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • aggression
  • dorsal raphe
  • medial amygdala
  • neurocircuit
  • optogenetics
  • orbitofrontal cortex

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • Novel roles for the GPI-anchor cleaving enzyme, GDE2, in hippocampal synaptic morphology and function
  • Upright posture: a singular condition stabilizing sensorimotor coordination
  • EEG Signatures of Auditory Distraction: Neural Responses to Spectral Novelty in Real-World Soundscapes
Show more Research Article: New Research

Cognition and Behavior

  • EEG Signatures of Auditory Distraction: Neural Responses to Spectral Novelty in Real-World Soundscapes
  • Excess neonatal testosterone causes male-specific social and fear memory deficits in wild-type mice
  • The effects of mindfulness meditation on mechanisms of attentional control in young and older adults: a preregistered eye tracking study
Show more Cognition and Behavior

Subjects

  • Cognition and Behavior
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.